This trial is comparing two different chemotherapy regimens to see which is more effective in treating patients with stage I-III breast cancer.
2 Primary · 7 Secondary · Reporting Duration: Biomarkers were measured by gene expression analysis before study entry. DFS was measured every 6 months for 5 years
3294 Total Participants · 6 Treatment Groups
Primary Treatment: AC regimen · No Placebo Group · Phase 3
Age 18+ · All Participants · 10 Total Inclusion CriteriaMark “Yes” if the following statements are true for you: